Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

The Morgan Stanley executive is retiring to run a foundation she started that aims to bring more young women into wealth ...

We recently compiled a list of the 10 AI News You Can’t Miss. In this article, we are going to take a look at where Broadcom ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...

Read here for the advantages and risks of Morgan Stanley's Series A preferred shares vs. CoCos, with insights on market ...

MS stock gains 32.4% this year. With the revival of global M&As, read on to know how 2025 will be for the stock and what ...

Nvidia’s (NASDAQ:NVDA) seemingly never-ending surge has been more muted in recent times. While sentiment has far from soured ...

Morgan Stanley has teamed up with cross-border money transmitter Wise to settle foreign-exchange payments for the investment ...

Investment bank Morgan Stanley on Friday issued a bullish report on artificial intelligence chipmakers, calling Nvidia stock ...